USE OF INTERFERON BETA-1A FOR INTRAMUSCULAR ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH MULTIPLE SCLEROSIS: EFFICACY, SAFETY AND ADHERENCE TO THERAPY
Immunomodulatory drugs reduce relapse rate and disease progression in relapsing-remitting multiple sclerosis but extensive data are not available on the effectiveness and tolerability of these drugs in childhood or adolescence. Interferon beta tolerability biased by frequency and method of drug admi...
Saved in:
| Main Authors: | O.V. Bykova, T.V. Sidorenko, A.N. Platonova, N.V. Gol’tsova, L.M. Kuzenkova, A.N. Boiko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2009-10-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/958 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICALLY ISOLATED SYNDROME IN CHILDREN AND ADOLESCENTS — RISK FACTORS FOR MULTIPLE SCLEROSIS AND PROSPECTS OF USING INTRAMUSCULAR INTERFERON β-1A
by: O.V. Bykova, et al.
Published: (2010-05-01) -
EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN
by: L. M. Kuzenkova, et al.
Published: (2013-09-01) -
System inflammation role in cardiovascular and obstetric pathology
by: M. B. Igitova, et al.
Published: (2009-02-01) -
Meningioma growth during interferon beta-1a treatment for multiple sclerosis Crescimento de meningeoma durante tratamento para esclerose múltipla com interferon beta-1a
by: Hugo Pereira Pinto Gama, et al.
Published: (2008-06-01) -
ACETAZOLAMIDE IN PEDIATRIC NEUROLOGY: HISTORY AND PERSPECTIVE OF CILNICAL USE
by: A.N. Boyko, et al.
Published: (2006-03-01)